About the Authors

Christine M. Fennessey

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Mykola Pinkevych

Affiliation Infection Analytics Program, Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, NSW, Australia

Taina T. Immonen

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Arnold Reynaldi

Affiliation Infection Analytics Program, Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, NSW, Australia

Vanessa Venturi

Affiliation Infection Analytics Program, Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, NSW, Australia

Priyanka Nadella

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Carolyn Reid

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Laura Newman

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Leslie Lipkey

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Kelli Oswald

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

William J. Bosche

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Matthew T. Trivett

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Claes Ohlen

† Deceased.

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

David E. Ott

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Jacob D. Estes

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Gregory Q. Del Prete

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Jeffrey D. Lifson

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Miles P. Davenport

keelebf@mail.nih.gov (BFK); m.davenport@unsw.edu.au (MPD)

Affiliation Infection Analytics Program, Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, NSW, Australia

Brandon F. Keele

keelebf@mail.nih.gov (BFK); m.davenport@unsw.edu.au (MPD)

Affiliation AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Competing Interests

CMF, TTI, PN, CR, LN, LL, KO, WJB, MTT, CO, DEO, JDE, GQDP, JDL, and BFK are employed by Leidos Biomedical Research Inc. All authors have declared that no competing interests exist.

Author Contributions

Conceptualization: CMF JDE GQD JDL MPD BFK. Data curation: CMF MP TTI AR PN MPD BFK. Formal analysis: CMF MP TTI AR VV PN MPD BFK. Funding acquisition: BFK. Investigation: CMF CR LN LL KO WJB MTT CO DEO BFK. Methodology: CMF MP TTI AR MPD BFK. Project administration: JDL MPD BFK. Resources: CO DEO MPD JDL BFK. Software: MP TTI AR PN MPD. Supervision: MPD BFK. Validation: BFK. Visualization: CMF MP TTI MPD BFK. Writing – original draft: CMF MP MPD BFK. Writing – review & editing: CMF MP JDE GQDP JDL VV MPD BFK.